FindTrial
Sign In

Clinical study on the prognostic evaluation of GDF15 in critically ill patients

Clinical study on the prognostic evaluation of GDF15 in critically ill patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400091418
Enrollment
Unknown
Registered
2024-10-28
Start date
2024-04-01
Completion date
Unknown
Last updated
2024-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

critical disease

Interventions

Research queue:None

Sponsors

The 2nd Affiliated Hospital of Harbin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1) Age = 18 years old 2) Patient admitted to intensive care unit

Exclusion criteria

Exclusion criteria: 1) Age75 years old 2) The patient refused to participate in the study 3) Previously participated in research 4) Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
Serum Growth differentiation factor 15;28-day all-cause mortality;—

Secondary

MeasureTime frame
7-day all-cause mortality;90-day all-cause mortality;180-day all-cause mortality;ICU length of stay;Mechanical ventilation time;The occurrence of cardiovascular events during hospitalization;APACHEII score;SOFA score;—

Countries

China

Contacts

Public ContactHan Yi

The 2nd Affiliated Hospital of Harbin Medical University

hanyi@jsph.org.cn+86 132 4583 8871

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026